| 标题 |
First-Line Pembrolizumab + Chemotherapy Versus Placebo + Chemotherapy for Persistent, Recurrent, or Metastatic Cervical Cancer: Final Overall Survival Results of KEYNOTE-826 |
| 网址 | |
| DOI | |
| 其它 |
期刊:Journal of clinical oncology : official journal of the American Society of Clinical Oncology 作者:Monk BJ; Colombo N; Tewari KS; Dubot C; Caceres MV; et al 出版日期:2023/12/20 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)